Exploring potential opportunities in subcutaneous delivery.

scPharmaceuticals is actively exploring the subcutaneous delivery of furosemide, with the goal of offering an outpatient solution through an 80mg/1ml auto-injector. The auto-injector is an investigational drug-device combination product featuring a fixed dose auto-injector designed to administer a single dose of furosemide.  It’s important to note that the auto-injector is currently under investigation and has not yet received approval from any regulatory agency.